Centre Number
Candidate Number
Write your name here
Surname
Other names
Total Marks
Paper Reference
     Turn over
*N37480A0124*
Edexcel GCE
Biology
Advanced Subsidiary
Unit 1:  Lifestyle, Transport, Genes and Health
Tuesday 11 January 2011 – Morning
Time: 1 hour 30 minutes
You do not need any other materials.
6BI01/01
Instructions
• Use black ink or ball-point pen.
• Fill in the boxes at the top of this page with your name, 
 
centre number and candidate number.
• Answer all questions.
• Answer the questions in the spaces provided 
 
– there may be more space than you need.
Information
• The total mark for this paper is 80. 
• The marks for each question are shown in brackets
 
– use this as a guide as to how much time to spend on each question.
• Questions labelled with an asterisk (*) are ones where the quality of your 
 
written communication will be assessed 
 
 – you should take particular care with your spelling, punctuation and grammar, as 
well as the clarity of expression, on these questions.
Advice
• Read each question carefully before you start to answer it.
• Keep an eye on the time.
• Try to answer every question.
• Check your answers if you have time at the end.
N37480A
©2011 Edexcel Limited.
1/1/1/1/1/
PMT


--- Page Break ---

2
*N37480A0224*
Answer ALL questions.
Some questions must be answered with a cross in a box 
. If you change your mind about an 
answer, put a line through the box 
 and then mark your new answer with a cross 
.
1 Cardiovascular diseases are very common in the Western World.
 
(a) Many cardiovascular diseases result from atherosclerosis.
 
 
Place a cross  in the box next to the correct word or words to complete each of 
the following statements.
 
 
(i) 
Atherosclerosis usually results from the formation of plaques inside
(1)
 
 
 
A arteries
 
 
 
B capillaries
 
 
 
C veins
 
 
 
D ventricles
 
 
(ii) The plaques begin to form after damage to
(1)
 
 
 
A endothelial cells
 
 
 
B epidermal cells
 
 
 
C red blood cells
 
 
 
D white blood cells
 
 
(iii) These cells may be damaged due to
(1)
 
 
 
A blood flowing slowly under low pressure
 
 
 
B blood flowing quickly under low pressure
 
 
 
C blood flowing slowly under high pressure
 
 
 
D blood flowing quickly under high pressure
 
 
(iv) The plaque consists of
(1)
 
 
 
A carbohydrate deposits
 
 
 
B fatty deposits
 
 
 
C plasma deposits
 
 
 
D protein deposits
PMT


--- Page Break ---

3
*N37480A0324*
Turn over
 
 
(v) The presence of a plaque in the vessels supplying blood to the brain could 
result  in
(1)
 
 
 
A cancer
 
 
 
B a heart attack
 
 
 
C kidney damage
 
 
 
D a stroke
PMT


--- Page Break ---

4
*N37480A0424*
 
(b) A clinical trial was carried out to investigate the effect of a drug on the volume of 
plaques in patients with atherosclerosis.
 
 
Forty patients with atherosclerosis were divided into two groups of twenty.  Each 
patient had the volume of their plaque determined.  One group was the control 
group and the treatment group took the drug daily for two months.
 
 
At the end of the two months, the volume of the plaque in each patient was 
determined again.  The mean change in volume of the plaque was calculated.
 
 
The results of the clinical trial are shown in the graph below.
+50 –
0 –
–50 –
–100 –
–150 –
Control 
group
Treatment 
group
Mean change in volume of plaque / mm3
PMT


--- Page Break ---

5
*N37480A0524*
Turn over
 
 
(i) 
Using the information in the graph, describe what the results of this trial 
show.
(2)
.................................................................................................................................................................................................................................................................................  
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
 
 
(ii) Suggest two reasons why the results of this trial do not indicate that this drug 
could be useful in treating patients with atherosclerosis.
(2)
1  ............................................................................................................................................................................................................................................................................  
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
2  ............................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
(Total for Question 1 = 9 marks)
PMT


--- Page Break ---

6
*N37480A0624*
2 Blood is carried around the body of many animals in different types of blood vessels.  
The structures of these blood vessels relate to their function.
 
(a) The table below refers to the structure of capillaries and veins.  If the statement is 
correct, place a tick (9) in the appropriate box and if the statement is incorrect, 
place a cross (8) in the appropriate box.
(3)
Type of blood 
vessel
Valves present along the 
length of the vessel
Wall consists of 
a single layer of 
cells
Endothelial cells 
present
Capillary
Vein
 
(b) Semilunar valves and elastic fibres are found in the aorta.
 
 
For each of these structures, describe its location in the aorta and explain its 
function.
 
 
Semilunar valves
(3)
Location  ........................................................................................................................................................................................................................................................
Function  .......................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
 
 
Elastic fibres
(3)
Location  ........................................................................................................................................................................................................................................................
Function  .......................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
(Total for Question 2 = 9 marks)
PMT


--- Page Break ---

7
*N37480A0724*
Turn over
3 Read through the following passage on the structure of DNA, then write on the 
dotted lines the most appropriate word or words to complete the passage.
(8)
 
A DNA molecule consists of two strands of mononucleotides.  Each of these strands
 
is twisted around the other, forming a .......................................................................... .
 
Each mononucleotide consists of a pentose sugar called .......................................................................... ,
 
a base and a .......................................................................... .  In each strand, the mononucleotides are
 
held together by .......................................................................... bonds.
 
The two strands are held together by complementary base pairing.  Adenine bonds
 
with .......................................................................... and cytosine bonds with .......................................................................... .
 
The name of the bond that forms between these bases is a 
 
..........................................................................  bond.  A DNA molecule that is composed of 34% adenine
 
will be composed of .......................................................................... % cytosine.
(Total for Question 3 = 8 marks)
PMT


--- Page Break ---

8
*N37480A0824*
4 Many animals have a heart and circulatory system.
 
(a) Give one reason why many animals have a circulatory system.
(1)
.................................................................................................................................................................................................................................................................................  
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
 
(b) The diagram below shows a section through a mammalian heart.
  
 
On the diagram, draw arrows to show the flow of blood into and through the right 
side of the heart during one beat of the heart.
(3)
 
(c) Explain why a mammalian heart is divided into a right side and a left side.
(2)
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
(Total for Question 4 = 6 marks)
Right side
Left side
PMT


--- Page Break ---

9
*N37480A0924*
Turn over
5 Thalassaemia is the name of a group of inherited blood disorders that affect the 
body’s ability to produce haemoglobin in red blood cells.  Red blood cells are 
produced in bone marrow.
 
Oxygen in the lungs binds to haemoglobin and is carried to the cells of the body to 
be used in respiration.
 
Beta thalassaemia is the result of a mutation in the gene coding for the β chain of 
haemoglobin.  If a person inherits gene mutations from both parents, this person 
will show symptoms of anaemia and will require blood transfusions.  Symptoms of 
anaemia include tiredness and breathlessness.
 
*(a) Using the information given above and your knowledge of gene mutation, 
suggest why a person with beta thalassaemia has symptoms of anaemia.
(4)
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
PMT


--- Page Break ---

10
*N37480A01024*
 
(b) If the phenotypes of the parents are known, the probabilities of having a child 
with beta thalassaemia, an unaffected child or a child who is a carrier, can be 
calculated.
 
 
Complete the table below to show the results of these calculations.
(4)
Parent 1
Parent 2
Probability  
of having a 
child with beta 
thalassaemia
Probability 
of having an 
unaffected 
child
Probability  
of having a 
child who is a 
carrier
Unaffected
carrier
no chance  
50%
50%
Carrier
carrier
Unaffected
has beta 
thalassaemia
Carrier
has beta 
thalassaemia
50%
no chance
50%
PMT


--- Page Break ---

11
*N37480A01124*
Turn over
 
(c) Gene therapy could potentially be used to treat beta thalassaemia.
 
 
Suggest how gene therapy could be carried out to treat this disorder.
(4)
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
(Total for Question 5 = 12 marks)
PMT


--- Page Break ---

12
*N37480A01224*
BLANK PAGE
PMT


--- Page Break ---

13
*N37480A01324*
Turn over
6 The size and solubility of molecules has an effect on their ability to be taken up by cells.
 *(a) Describe an experiment you have carried out to investigate the permeability of 
cell membranes.
(5)
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
PMT


--- Page Break ---

14
*N37480A01424*
 
(b) An investigation was carried out into the permeability of a cell membrane to a  
number of different non-polar, organic molecules.  The molecules differed in their 
size and in their solubility in oil compared with their solubility in water.
 
 
The higher the solubility, the more soluble the molecule is in oil compared with 
water.
 
 
The graph below shows the results of this investigation.
 
 
The size of the circle drawn on the graph indicates the size of the molecule; the 
larger the circle, the larger the molecule.
 
 
(i) 
Describe what relationship, if any, there is between the permeability of this 
cell membrane and the size of the molecules.
(1)
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
 
 
(ii) Describe what relationship, if any, there is between the permeability of this 
cell membrane and the solubility of the molecules in oil compared with 
water.
(1)
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
1.0 –
0.75 –
0.50 –
0.25 –
0 –
–
1
–
2
–
3
–
4
–
0
Solubility in oil compared to water / arbitrary units
Membrane permeability / arbitrary units
PMT


--- Page Break ---

15
*N37480A01524*
Turn over
 
 
(iii) Water is able to diffuse through a cell membrane, even though it is a polar 
molecule.
 
 
 
On the graph, draw a circle, labelled W, to indicate the permeability of the cell 
membrane to water.  The size of the circle should represent the size of the 
water molecule.
(2)
 
 
(iv) Use your knowledge of the structure and properties of cell membranes to 
explain the results of this investigation.
(3)
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
(Total for Question 6 = 12 marks)
PMT


--- Page Break ---

16
*N37480A01624*
7 Some fatty acids are classed as essential fatty acids.  These fatty acids need to be 
included in our diet, because the human metabolism cannot synthesise them.
 
Omega 3 and omega 6 are two examples of essential fatty acids.
 
(a) The diagrams below represent the structures of the fatty acids omega 3 and 
omega 6.
 
 
Omega 3
 
 
Omega 6
 
 
(i) 
Using the diagram of omega 3 above, describe its structure.
(2)
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
 
 
(ii) Give one difference between the structure of omega 3 and the structure of 
omega 6.
(1)
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
HO
C
O
HO
C
O
PMT


--- Page Break ---

17
*N37480A01724*
Turn over
 
 
(iii) The diagram below shows a more simplified structure of omega 3.
 
 
 
A glycerol molecule is drawn below.  Use these diagrams to show how 
one omega 3 molecule bonds to the glycerol molecule, by means of a 
condensation reaction, during the synthesis of a triglyceride.
(3)
HO
C
O
H
C
C
C
H
H
OH
H
OH
H
OH
PMT


--- Page Break ---

18
*N37480A01824*
 
(b) Omega 3 and omega 6 are both present in animal fats.
 
 
The proportion of omega 3 and omega 6 in animal fat has been shown to depend 
on the diet of the animals.
 
 
In an investigation, the masses of omega 3 and omega 6, per gram of fat, were 
determined in the fat from cows fed on a diet containing 100%, 67% or 33% grass.
 
 
The results of this investigation are shown in the graph below.
 
 
Describe what effect the percentage grass content of a cow’s diet has on the 
proportion of omega 3 and omega 6 in its fat.
(3)
.................................................................................................................................................................................................................................................................................  
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
Masses of omega 3 and omega 6 / mg per gram of fat
45 –
40 –
35 –
30 –
25 –
20 –
15 –
10 –
5 –
0 –
100%
67%
33%
omega 3
omega 6
Percentage of grass in diet (%)
PMT


--- Page Break ---

19
*N37480A01924*
Turn over
 
(c) A high ratio of omega 6 to omega 3 has been linked to an increased risk of 
cardiovascular disease (CVD).
 
 
(i) 
High blood pressure is another factor that increases the risk of CVD.
 
 
 
Give two other dietary factors that increase the risk of CVD.
(1)
1  ............................................................................................................................................................................................................................................................................
2  ............................................................................................................................................................................................................................................................................
 
 
(ii) Omega 3 has been shown to lower blood pressure.  Antihypertensives can 
also be used to lower blood pressure.
 
 
 
State one risk of using antihypertensives.
(1)
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
(Total for Question 7 = 11 marks)
PMT


--- Page Break ---

20
*N37480A02024*
8 Enzymes, messenger RNA (mRNA) and transfer RNA (tRNA) are involved in the 
synthesis of proteins.
 
(a) The diagram below represents the structure of an enzyme.
 
 
Each circle represents an amino acid.
 
 
(i) 
An enzyme is a protein and has a primary structure.
 
 
 
Explain the meaning of the term primary structure.
(2)
.................................................................................................................................................................................................................................................................................  
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................  
.................................................................................................................................................................................................................................................................................
Lys
Lys
Lys
Lys
Lys
Lys
Lys
Glu
Glu
Thr
Thr
Thr Thr
Thr
Thr
Ala Ala Ala
Ala Ala
Phe
Arg
Arg
Gln His
Ser
Ser
Ser
Ser
Ser
Ser
Ser
Ser
Ser
Met
Met
Asp
Asp
Thr
Thr
Thr
Asn
Asn
Tyr
Cys
Cys
Ile
Met Met Gln
Gln
Glu
Ser
Ser
Ser
Ser
Gly
Arg
Arg
Asn
Asn
Leu
Tyr
Val
Val
Pro
Ala
Ala
Ala
C
O
OH
Asp
Asp
Tyr
Pro
Phe His
Val
Val
Val
Val
Val
Val
Pro
Pro
Asn
Asn
Asn
Asn
Asn
Asn
Lys
His
Ile
Ile
Ala
Ala
Ala
Ala
Glu
Asp
Ser
Ser
Leu
Gln
Gly
Gly
Cys
Cys
Cys
Cys
Cys
Cys
Tyr
Tyr
Tyr
Thr
Lys
Lys
Gln
Gln
Gln
Glu
His
Val
Phe
N
H
H
PMT


--- Page Break ---

21
*N37480A02124*
Turn over
 
 
(ii) Using the diagram and your own knowledge of enzymes, explain the 
importance of the primary structure of an enzyme to its function.
(5)
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
 
(b) Describe the roles of messenger RNA (mRNA) and transfer RNA (tRNA) in protein 
synthesis.
 
 
(i) 
Messenger RNA
(3)
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
PMT


--- Page Break ---

22
*N37480A02224*
 
 
(ii) Transfer RNA
(3)
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
.................................................................................................................................................................................................................................................................................
(Total for Question 8 = 13 marks)
TOTAL FOR PAPER = 80 MARKS
PMT


--- Page Break ---

23
*N37480A02324*
BLANK PAGE
PMT


--- Page Break ---

24
*N37480A02424*
BLANK PAGE
PMT
